These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 4098472)

  • 41. Von Willebrand's disease: platelet nucleotide alterations in a case with marked platelet adhesiveness and aggregation defects.
    Valente A; Volpe E; Gandini M; Buonanno G
    Acta Haematol; 1972; 47(3):182-91. PubMed ID: 4624256
    [No Abstract]   [Full Text] [Related]  

  • 42. Some effects of a microcrystalline collagen preparation on blood.
    Mason RG; Read MS
    Haemostasis; 1974; 3(1):31-45. PubMed ID: 4215704
    [No Abstract]   [Full Text] [Related]  

  • 43. Platelet studies in von Willebrand's disease, especially on the platelet adhesion to subendothelium and platelet binding with factor VIII.
    Yamada K; Inagaki M; Fukumoto T; Meguro T
    Nihon Ketsueki Gakkai Zasshi; 1979 Dec; 42(6):864-71. PubMed ID: 121661
    [No Abstract]   [Full Text] [Related]  

  • 44. [Effect of aspirin on the blood platelets in children].
    Nakasawa S; Yamada Z; Yamada K
    Nihon Shonika Gakkai Zasshi; 1971 Oct; 75(10):932-7. PubMed ID: 5317038
    [No Abstract]   [Full Text] [Related]  

  • 45. Shortening of bleeding time by 1-deamino-8-D-arginine vasopressin in various bleeding disorders.
    Kobrinsky NL; Israels ED; Gerrard JM; Cheang MS; Watson CM; Bishop AJ; Schroeder ML
    Lancet; 1984 May; 1(8387):1145-8. PubMed ID: 6144876
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Letter: Nature of the von Willebrand factor.
    Weiss HJ
    N Engl J Med; 1974 Feb; 290(8):464. PubMed ID: 4544034
    [No Abstract]   [Full Text] [Related]  

  • 47. Factor-VIII-related antigen in platelets.
    Howard MA; Montgomery DC; Hardisty RM
    Thromb Res; 1974 May; 4(5):617-24. PubMed ID: 4545781
    [No Abstract]   [Full Text] [Related]  

  • 48. [Chromatographic and immunological studies in patients with von Willebrand-Jürgens syndrome (vWJS) and with a variant of this disease].
    Hasler K; Böttcher D; Retzbach I
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():803-8. PubMed ID: 306174
    [No Abstract]   [Full Text] [Related]  

  • 49. [Willebrand's disease and dentistry].
    Artis JP; Artis M; Alexander P
    Chir Dent Fr; 1976 Dec; 46(330):55-7. PubMed ID: 1088748
    [No Abstract]   [Full Text] [Related]  

  • 50. A human myeloma-produced monoclonal protein directed against the active subpopulation of von Willebrand factor.
    Bovill EG; Ershler WB; Golden EA; Tindle BH; Edson JR
    Am J Clin Pathol; 1986 Jan; 85(1):115-23. PubMed ID: 3079626
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Von Wollebrand's disease with normal Factor VIII activity in a homozygote.
    Holmberg L; Rasović N; Nilsson IM
    Haemostasis; 1974; 3(4):237-46. PubMed ID: 4549210
    [No Abstract]   [Full Text] [Related]  

  • 52. Proceedings: Abnormal factor VIII in von Willebrand's disease.
    Thompson C; Forbes CD; Prentice CR
    Br J Haematol; 1974 Sep; 28(1):144. PubMed ID: 4547281
    [No Abstract]   [Full Text] [Related]  

  • 53. Canine von Willebrand's disease.
    Dodds WJ
    J Lab Clin Med; 1970 Nov; 76(5):713-21. PubMed ID: 5312238
    [No Abstract]   [Full Text] [Related]  

  • 54. Dissociation between human platelet agglomerating activity and factor VIII procoagulant activity of bovine plasma preparations by chemical treatment. II. Effect of periodate oxidation.
    Mello Périssé AC; Soria J; Soria C; Mester L
    Pathol Biol (Paris); 1973 Nov; 21():Suppl:63-5. PubMed ID: 4357696
    [No Abstract]   [Full Text] [Related]  

  • 55. Dissociation between factor VIII (activity and antigen) and ristocetin-induced platelet aggregation in von Willebrand's disease.
    Barbui T; Dini E
    Acta Haematol; 1975; 53(1):44-8. PubMed ID: 807074
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cell membrane damage, platelet stickiness and some effects of aspirin.
    O'Brien JR
    Br J Haematol; 1969 Dec; 17(6):610-1. PubMed ID: 5357755
    [No Abstract]   [Full Text] [Related]  

  • 57. [Studies on the fibrin stabilizing factor in thrombocytes].
    Heene DL
    Verh Dtsch Ges Inn Med; 1969; 75():467-70. PubMed ID: 5312825
    [No Abstract]   [Full Text] [Related]  

  • 58. Platelet function in recipients of platelets from donors ingesting aspirin.
    Stuart MJ; Murphy S; Oski FA; Evans AE; Donaldson MH; Gardner FH
    N Engl J Med; 1972 Nov; 287(22):1105-9. PubMed ID: 5082189
    [No Abstract]   [Full Text] [Related]  

  • 59. The effect of dihydroergotamine on platelets, coagulation and fibrinolysis, studied in healthy humans and in dogs.
    Lindblad B; Bergqvist D; Hedner U
    Thromb Res; 1983 Oct; 32(1):35-44. PubMed ID: 6419372
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Relation between bleeding time and platelet connective tissue reaction after aspirin.
    Hirsh J; Street D; Cade JF; Amy H
    Blood; 1973 Mar; 41(3):369-77. PubMed ID: 4690136
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.